Crispr Therapeutics AG CRSP
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
CRISPR Therapeutics AG is a Swiss biotechnology company focused on gene editing-based medicines for serious diseases. The company develops therapies using its proprietary CRISPR/Cas9 platform, which enables precise changes to DNA and supports a portfolio of programs across hemoglobin disorders, oncology, regenerative m…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountrySwitzerland
Employees393
TickerCRSP
Statistics
Market Cap$5.05B
Revenue (TTM)$3.5M
Net Income-$581.6M
Net Margin-16569.8%
EPS$-6.47
P/E-7.77
P/S1205.67
P/B2.67
EV/EBITDA-5.86
ROE-31.2%
Dividend Yield—
Price$52.36
Data: Twelve Data · Revenue = mcap / P/S